Authors
Alessandro G Salerno, Amarylis C B A Wanschel, Giovana Y A Mascoli, Seonwook Kim, Elena Boudyguina, Reto Asmis
Published in
Frontiers in immunology. Volume 17. Pages 1829375. Epub Jun 30, 2026.
Abstract
Monoamine oxidase A (Mao A) is a mitochondrial enzyme responsible for the degradation of monoaminergic neurotransmitters. While pharmacological inhibition of Mao A has been reported to improve outcomes in experimental autoimmune encephalomyelitis (EAE), the role of Mao A in immune cells on disease progression was unknown.
To address this question, we generated mice with conditional Mao A deletion restricted to hematopoietic cells (Mao ALeuko -/-), including circulating immune cells, and induced EAE by immunizing the mice with the MOG35-55 peptide. Disease severity, ataxia, inflammation, and demyelination were assessed.
Mao ALeuko -/- female mice exhibited significantly accelerated weight loss, worsened ataxia, and a 2.2-fold increase in EAE severity compared with controls. Histological analyses revealed increased inflammation and enhanced demyelination in the lumbar spinal cords of Mao ALeuko -/- mice. Immunohistochemistry revealed increased IBA-1+ and CD68+ staining in the spinal cord, consistent with enhanced microglia and macrophage accumulation and activation and exacerbated neuroinflammation. However, no differences in CD3+ T-cells levels were observed between female Mao ALeuko -/- and Vav-i Cretg/wt EAE mice. These effects were restricted to female mice. No significant differences were observed in disease course or pathology between male Mao ALeuko -/- and control mice. This study identified hematopoietic Mao A as a novel critical regulator of neuroimmune crosstalk, with loss of Mao A function exacerbating inflammation, demyelination, and neurological deficits in female but not male EAE mice.
PMID:
42454033
Bibliographic data and abstract were imported from PubMed on 15 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0